Our experts specialize in these core areas:

• Advanced Heart Failure & Transplant:
  Led by James Fang, MD, FACC, Chief Medical Officer of the UH Harrington-McLaughlin Heart & Vascular Institute, UH offers highly specialized therapies for the most challenging cardiovascular problems, particularly for "no option" patients, through our heart failure, transplant and mechanical assist programs. UH Case Medical Center is the first institution in Northeast Ohio to implant the Jarvik 2000 and Impella investigational heart pumps, and we can provide temperature modulation therapy and laser technology as a way to deliver cardiovascular stem cells to the heart in relevant cases.
• Electrophysiology:
  The Electrophysiology Center of the UH Harrington-McLaughlin Heart & Vascular Institute at UH Case Medical Center – one of the first such facilities in the United States – is recognized as a leading provider of diagnostic and individualized-treatment options for cardiac arrhythmias. Directed by Mauricio Arruda, MD, we offer the latest technological advances in stereotactic magnetic navigation, 3-D mapping systems and intracardiac echocardiography, implantable cardiac device (ICD) therapy, as well as cardiac resynchronization therapy.
• Stem Cell and Regenerative Medicine:
  The stem cell and regenerative medicine program is co-directed by Marco Costa, MD, PhD, and Mukesh Jain, MD, of the UH Harrington-McLaughlin Heart & Vascular Institute, in collaboration with Stan Gerson, MD, of the UH Ireland Cancer Center. We have united international leaders in stem cell biology, therapeutics, and clinical medicine to develop novel cell-based therapeutics. We are pioneering an exciting research area that we believe will make rapid inroads into patient care for heart disease, cancer and other disorders.
• Cardiovascular Imaging:
  The Cardiovascular Imaging Center of the UH Harrington-McLaughlin Heart & Vascular Institute, directed by Robert Gilkeson, MD, provides unsurpassed expertise in diagnostic imaging including MRI, CT angiography and nuclear medicine. Our accredited Non-Invasive Cardiology Adult Echocardiography Laboratory is one of the largest in Northeast Ohio. Advances in the nationally-renowned Case Center for Imaging Research will accelerate the latest imaging technologies into the clinical area and improve patient care.
• Valve Heart Disease:
  Led by Alan Markowitz, MD, Chief Surgical Officer, and James Fang, MD, FACC, Chief Medical Officer, UH Harrington-McLaughlin Heart & Vascular Institute, the Heart Valve Center focuses on the evaluation, diagnosis, and treatment of patients with complex valvular heart disease, with a unique expertise in innovative valve repair and re-operative procedures. Interdisciplinary pre-operative evaluation, peri-operative collaboration, and team-based post-operative management is leveraged to optimize outcomes in mitral, aortic, and tricuspid disease.
• Interventional Cardiology:
  The Interventional Cardiovascular Center of the UH Harrington-McLaughlin Heart & Vascular Institute is a world academic leader in advanced diagnosis and therapies for patients with cardiac and vascular disease. Led by Marco Costa, MD, PhD, a multi-disciplinary team performs annually >5,000 minimally invasive procedures in state-of-the-art facilities. The center is equipped with the latest imaging technology, including remote stereotaxis magnetic navigation, 3D intravascular and intracardiac ultrasound, and electromechanical mapping for stem cell therapy. The center is a pioneer in optical coherence tomography, a revolutionary technology that provides microscopic images of the coronary arteries using light. The Center's faculty members are national principal investigators for the latest generation drug-eluting stent trials. The interventional faculty provides unique expertise in the percutaneous treatment of complex coronary artery disease, structural heart disease such as closure of patent forman ovale (PFO) in patients who suffered stroke, peripheral intervention for patients with lower extremity, renal, and carotid artery disease as well as advanced cardiac valve therapies, such as mitral and aortic valvuoplasty.